Rutgers Engineers Developing Rapid Breathalyzer Test for COVID-19

New Brunswick, N.J. (April 30, 2021) – Rutgers University–New Brunswick engineering professors Edward P. DeMauro, German Drazer, Hao Lin and Mehdi Javanmard are available for interviews on their work to develop a new type of fast-acting COVID-19 sensor that detects the presence…

Rutgers University’s Resilient, Innovative Year Confronting COVID-19

The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.

FDA Approves First At-Home Saliva Collection Test for Coronavirus

Rutgers’ RUCDR Infinite Biologics received an amended emergency use authorization from the FDA late Thursday for the first SARS-CoV-2 coronavirus test that will allow people to collect their own saliva at home and send to a lab for results. The decision follows the FDA’s recent emergency approval to RUCDR Infinite Biologics for the first saliva-based test, which involves health care workers collecting saliva from individuals at testing sites.